Abstract
In healthy couples over half of the conceptions result in failed pregnancy and around 30% of them occur during implantation defining it as a rate-limiting step for the success of native and in vitro fertilization. The understanding of the factors regulating each step of implantation and immune recognition is critical for the pregnancy outcome. Creation of 3D-cell culture models, such as spheroids and organoids, is in the focus of placental tissue engineering in attempt to resemble the in vivo complexity of the maternal-fetal interface and to overcome the need of laboratory animals and human embryos. We constructed stable, reliable, and reproducible trophoblast Sw71 spheroids which are functional independently of the serum level in the culture media. These models resemble the hatched human blastocyst in size, shape and function and are useful for in vitro studies of the in vivo concealed human implantation. Since Sw71 spheroids produce HLA-C, the only classical MHC molecule indispensable for establishment of the immune tolerance and proper human implantation, they are applicable for the evaluation not only of implantation itself but also of maternal-trophoblasts immune interactions. In addition, Sw71-blastocyst-like spheroids are manipulable in low-volume platform, easy to monitor and analyze automatically under treatment with favorable/detrimental factors.
Similar content being viewed by others
Introduction
Human implantation is a highly complex and still unsolved phenomenon by which the conceptus is transported to its site in the uterus, oriented properly, and then attached by adhesion and trophoblastic penetration into the receptive and modified endometrium (decidua) about day 6 post-conception1. In healthy couples over half of the conceptions result in failed pregnancy and around 30% of them occur during implantation defining it as a rate-limiting step for the success of native and in vitro fertilization (IVF)2,3,4. Aberrant implantation can cause a variety of clinical disorders including miscarriage, intrauterine growth retardation and pre-eclampsia5. Except biological, human implantation is an immune paradox because the semi-allogeneic embryo is normally accepted, indicating the presence of active mechanisms of immune tolerance and/or fetus strategies to avoid an attack by the maternal immune system. Such a strategy is the lack of HLA class I molecules on the villous trophoblasts and their atypical expression by the extravillous trophoblasts (EVTs) contacting with maternal immune cells into decidua. In uncomplicated pregnancies EVTs invade through the decidua and express the non-classical (invariant) HLA class I molecules HLA-G and HLA-E6,7 and the classical polymorphic HLA-C molecule8,9. The paternal inherited HLA-C variants, expressed on the invading trophoblast are recognized by Killer Ig-like Receptors (KIRs) on maternal immune cells such as cytotoxic T and NK cells8,9. Some maternal/fetal KIR/HLA-C combinations might be favorable to trophoblast cell invasion and protective for implantation, and others could initiate allo-responses or insufficient placental growth8,9. Within the context of the current state of knowledge, human implantation remains an obscure process and real barrier to assisted reproduction techniques, introduced many years ago10 and therefore, the possibility for clinical intervention is still limited. Thus, understanding the factors regulating each step of implantation and immune recognition is critical for improving pregnancy outcome. The mode of implantation in humans differs considerably from other mammalian species resulting in the restricted range of functional experimental models8,11. Regulations around the world including USA and EU countries like Bulgaria, restrain in vitro studies using human blastocysts12,13. Ethical constraints and restricted access to early gestational tissue strongly limit our knowledge of the human placenta in the earliest stages of implantation. Thus, human trophoblast models, that adequately mimic trophectoderm development during implantation, are urgently needed for “better understand pregnancy loss and infertility without experimenting on human embryos”14. Traditional two-dimensional (2D) cell culture models lack physiologically relevant environmental conditions in terms of physical and biochemical settings. Therefore, studies turned to construction of three-dimensional (3D) organoid and spheroid systems where cells benefit from cell to cell and cell to extracellular matrix (ECM) contacts and exist in a more biochemically relevant state with gradients of oxygen, nutrients, and metabolites15,16. Different types of cells were used including cancer cell lines, embryonic stem and reprogrammed to stem somatic cells. They all present advantages and disadvantages and show variating success for formation of blastocyst-like structures17,18,19. In a series of elegant experiments, G. Mor’s group created 3D trophoblast cell line Swan71 (Sw71) and blastocyst-like structures during the peri-implantation period20,21,22. In this study we extended the data on the morphology and behavior/function of the 3D Sw71 models in microenvironment with different serum level and tested their HLA-C expression/production in view of the applicability of this model for the evaluation of maternal–trophoblast immune interactions in (un)successful human implantation.
Results
Monitoring of 3D Sw71 trophoblast models’ generation and morphology
Generation of 3D spheroids
The reproducibility of the establishment of 3D Sw71 spheroids was confirmed by 30 independent experiments performed mainly by two operators. We obtained over 70% viable spheroids from each experiment. Within 48 h we obtained a stable, self-assembled, round shaped, multi-layer relatively symmetric 3D spheroids (roundness index = 0.96 ± 0.04). The Sw71 cells cultured in a U-bottom 96 well low attachment plates initially formed loose aggregate (0–8 h), followed by compaction (12–24 h) and formation of single differentiated, stable spheroid with an intact periphery (24–48 h, Fig. 1a). The spheroids were monitored with or without a live cell imaging system; in bright, phase contrast, fluorescent modes, overlayed visualizations were easily obtained (experiments 1–3, Fig. 1b). Interestingly, the presence of non-organic contamination (dust, filaments etc.) in the wells did interfere with the shape and size but did not disturb the aggregation and formation of the 3D structures (experiment 4, Fig. 1b) as well as their functionality. We found that the spheroids’ generation process was particularly sensitive to humidity. In absence of optimal moisture, spheroids disintegrated into cell clusters, and when the humidity was normalized, their structure was restored (experiment 5, Fig. 1b) with preserved functionality in 97% of such rescued spheroids migrated. In general, plate defects did not interfere with spheroids’ differentiation, but compromised the quality of the images (experiment 6, Fig. 1b).
Morphology of Sw71 spheroids
Our next objective was to characterize the spheroids by determining three morphological parameters—mean spheroid diameter, surface, and volume. Measurements from 10 independent experiments including over 100 spheroids was performed and exemplified in Fig. 1c.1. We determined the average of the two largest perpendicular diameters, the area using the ECHO software and the formula V = 0.52 × 22 × 1 (Fig. 1c.1). Results revealed that on day 0 (D0) the mean diameter of the spheroids was 1.402 ± 110.60 mm, and the average surface was 1.487 ± 0.234 mm2. Between D0 and day 2 (D2) significant compactization was noted as the spheroids decreased in size to 466 ± 28.45 µm diameter and 0.170 ± 0.023 mm2 surface on day 1 (D1) and 425 ± 27.14 µm diameter and 0.143 ± 0.018 mm2 surface at D2 (Fig. 1c.2,c.3 respectively, p = 0.0001). The mean spheroid volume showed the same tendency (1.492 ± 0.355 mm3 at D0, 0.055 ± 0.009 mm3 on D1 and 0.041 ± 0.007 mm3 at D2, p = 0.0001). Once achieving compactization on D2, the fully differentiated spheroids can be transferred from the ULA plate to other plates, maintaining their integrity in spite of the manipulations. Interestingly, right after transfer to fresh media we can observe a significant decrease in size to 348 ± 30.99 µm diameter (Fig. 1c.2). When the models were kept in the ULA plate for a longer period (until day 4) without additional feeding, a considerable shrink was observed (Fig. 1c.3). The spheroids were very stable, maintaining their morphology up to 7–8 days when first signs of spheroid disintegration were observed. Around day 14 a large halo with de-attached dead cells in the periphery of the spheroids was present (Fig. 1d). Consequently, we demonstrate that the spheroids are functional and available for experiments 2 days after their differentiation and remain viable with preserved morphology up to 2 weeks.
Assessment of the function of Sw71 trophoblast spheroids
Attachment on epithelial endometrial cells
The first step in blastocyst implantation is the adhesive interaction between the trophoblast and endometrial epithelium. This is a crucial step for the blastocyst penetration and subsequent invasion/migration during successful implantation. To evaluate the capacity of the spheroids to attach to the epithelium, we transferred differentiated spheroids on an epithelial cells monolayer and incubated the cultures for 24 h with horizontal shaking of 1000 or 3000 rpm at 1st, 2nd, 4th and 24th hour. Over 95% of the spheroids were attached to the epithelium proved by shake at 1000 rpm. We tested the impact of the media and observed that the highest number of the attached spheroids (98%) were those cultured in Opti-MEM condition compared to lsDMEM/F12 (96%) and hsDMEM/F12 (92%, Fig. 2a–c). Interestingly, when the shaking was increase to 3000 rpm we found an attachment rate as follows: 100% in Opti-MEM, 96% in lsDMEM/F12 and 88% in hsDMEM/F12. The earliest time-point for firm attachment of the spheroids to the epithelium regardless of the shake intensity and media’s serum levels was 4th hour (Fig. 2a–c) when we were able to observe an epithelial-like reaction at the site of the spheroid attachment (Fig. 2d).
Migration and invasion capacity
Trophoblast migration and invasion into decidua is a major step on establishing placentation. These important events determine the ability of trophoblasts to reach the glandular histotrophic nutrition and then by invading deeply to remodel uterine spiral arteries and thus to establish functional placenta. To determine the migration properties of Sw71 spheroids we transfer single spheroids to regular tissue culture 96 well plated and monitored them for 48 h using life imaging. Time lapse analyses revealed that the spheroids attached within 10–12 h, followed by a well synchronized migratory process, where trophoblast cells emerged from the spheroid’s periphery and continued migrating throughout the surface of the well (Fig. 3a). The highest migration capacity of Sw71 spheroids was detected in Opti-MEM (96%), followed by hsDMEM/F12 (95%) condition, but the serum reduction from 10 to 1% decreased the migration rate to 85% (in lsDMEM/F12). Moreover, 16% of these migrations were characterized with formation of large central lacuna (Fig. 3b.3). In the serum-free media (sfDMEM/F12) 52% of the tested spheroids migrated (Fig. 3b.1), 27% showed initial migration at D1 interrupted on D2 (Fig. 3b.4) and 21% did not migrated at all. In general, 15% of all tested spheroids did not migrate at all, most of them being in no or low serum conditions (Fig. 3b.5). The most frequent migration pattern was radial (69%), independent of the media or serum concentrations (Fig. 3b.2). The quantitative analysis showed no significant difference in the spheroids’ migration area on D2, regardless serum content (p = 0.59, Fig. 3c). When stained with Trypan blue for vitality most of the cells migrating out of the spheroid were alive, elongated in shape and colorless, but some dead cells were also present, being round and blue (Fig. 3d).
To test the capacity of the spheroids to invade, we transfer single spheroids to the top of 50% Matrigel in different media conditions and monitored them using life imaging. Over 81% of Sw71 spheroids showed propensity for spontaneous invasion independent of the medium. The highest invasion rate was found in Opti-MEM culture (86%) compared to lsDMEM/F12 (83%) and hsDMEM/F12 (75%) cultures (Fig. 4a,b,c). The invasion emerged after D2 and was characterized by flattening out of the trophoblast cells from the periphery of the spheroids and formation of invadosomes (Fig. 4d,e). These invasive projections penetrate the Matrigel and continue growing in radial (“path-generating”) mode in a time-dependent manner. Although we detected amoeboid (“path-finding”) type of invasion in some spheroids (2 out of 75 tested, 1 in hsDMEM/F12 and 1in lsDMEM/F12, Fig. 4e), the radial pattern of invasion was the most observed (Fig. 4a–d). The invasion process could be observed up to 10 days, especially in hsDMEM/F12 cultures. In summary, Sw71 spheroids demonstrate pronounced invasiveness and ability to form projections that resemble chorionic villi structures (Fig. 4c).
Sw71 spheroids express and produce HLA-C molecule
Trophoblast cells are the primary fetal cells directly in contact with the maternal immune system and expression of HLA-C is a critical component of proper immune recognition. Our next step was to evaluate whether Sw71 spheroids express/produce HLA-C molecule as compared to early placenta chorionic villi (Fig. 5a,b). First, we cultured early placenta-derived explants for 72 h to obtain EVTs and confirm their HLA-C expression. The human trophoblast explants remained vital for several days as proven by the presence of well visible blood vessels and the formation of capping mass (Fig. 5a.2). Following attachment, placental explants formed structures resembling the anchoring chorionic villi around which the expansion of EVTs was observed. As shown these EVTs were positive for trophoblasts markers HLA-C (Fig. 5a.3, left and Fig. 5b.1, up) and HLA-G (Fig. 5b.1, down). In addition, we stained paraffin embedded trophoblasts tissue for HLA-C. As shown in Fig. 5a.3, an anchoring villa of human early placenta containing trophoblasts column with EVTs positive for HLA-C. Then we stained Sw71 cells in monolayer as well as Sw71 spheroids for HLA-C. The results showed strong HLA-C reaction in both Sw71 cells as monolayer (2D, Fig. 5b.2) and in Sw71 spheroids (3D, Fig. 5b.3), including in the cells migrating from the spheroids. We stained in the same manner for HLA-G and as found Sw71 spheroids expressed HLA-G (Fig. 5b, last column). Next, we evaluated the capacity of the Sw71 2D and 3D cultures to produce soluble HLA-C (sHLA-C). We measured HLA-C in the supernatants from these cultures by ELISA. Both, monolayer, and spheroids express detectable levels of sHLA-C (11.80 ± 1.13 ng/ml, n = 6 and 5.68 ± 2.66 ng/ml, n = 11, respectively (Fig. 5c). Of note, Sw71 spheroids secreted comparable amount of sHLA-C to that of primary trophoblasts (5.68 ± 2.66 ng/ml vs. 6.7 ± 1.99 ng/ml, n = 3, p = 0.76, Fig. 5c) independently of the serum level in the medium of both cultures (1% for Sw71 spheroids and 10% for the explants). Also, there was no significant difference in the HLA-C production by migrating and non-migrating Sw71 spheroids (5.76 ± 2.69 ng/ml, n = 7 vs. 5.54 ± 3.00 ng/ml, p = 0.95). The sHLA-C was abundantly present in sera of pregnant and non-pregnant women without any difference (1576 ± 299 ng/ml, n = 12 vs. 1547 ± 114 ng/ml, n = 4, p = 0.67, Fig. 5c).
Discussion
In this study we constructed stable, reliable, and reproducible trophoblast Sw71 spheroids which are functional regardless the serum level in the culture media. These models were manipulable in low-volume platform and easy to monitor and analyze automatically. Importantly, Sw71 spheroids expressed and produced HLA-C molecule similarly to the native 3D trophoblasts explants derived from early pregnancy human placenta. The creation of three-dimensional cell culture model systems, such as spheroids and organoids, is in the focus of placental tissue engineering. They better resemble the complexity of the in vivo microenvironment at maternal–fetal interface (MFI) during human implantation and overcome the need for experimental work with specimens, presenting strong ethical and practical constraints12,13,14. The successful implantation requires efficient apposition, adhesion/attachment, invasion and migration into decidual stroma, glands and blood vessels until the embryo is steadily implanted within the uterine mucosa1,8,23. Blastocyst models using trophoblast-derived choriocarcinoma cell lines have been used extensively but these cells are malignant and tumorigenic, differing from primary tissues in trophoblast-specific markers, as well as human leukocyte antigen (HLA) status24,25,26. Recently embryonic stem cells or reprogrammed to stem somatic cells were used for formation of blastocyst-like structures with higher accuracy in the morphology17,18,19 (presence of different cell types at low numbers, of “blastocoel” cavity) but they are hardly achievable for technical and ethical reasons thus limiting their use as experimental models in many laboratories. On the other hand, primary trophoblasts, isolated from first-trimester placenta, can hardly be manipulated since they rapidly cease proliferation and fade away. Here we confirm the successful, accessible, feasible and reproducible generation of spheroids from immortalized, non-cancer, first trimester trophoblast cell line Sw7120,21,22 with standard cell culture equipment and techniques. The yield of fine, uniform and differentiated Sw71 spheroids, resembling the shape, size, and behavior of the hatched human blastocyst during the peri-implantation period, was over 70% per experiment. As compared to unexpanded blastocyst within the zona pellucida27,28, Sw71 spheroids are about two times larger in diameter. It is important to note that except specific morphology and size the established 3D models for evaluation of human implantation must have the ability to attach, migrate and invade22. Sw71 spheroids in our hands showed functional capacity as “destined to implant” structures determined rather by their trophoblast origin, and independent of the microenvironment serum levels. Low (1%) and reduced (below 10%) serum levels promoted attachment and invasion while high serum levels (10%) facilitated spheroid migration. Although the Opti-MEM condition brought higher migration rate, and there were nice results in low and no serum media (also despite the lower rate), the serum is not the determinative factor for the migration process. Another important finding was that 10% FCS in the culture media protects the spheroids against unfavorable environmental factors. These results are in line with previous observations showing that serum supplementation may improve embryo culture outcomes but is not essential for IVF early embryo culture and transfer29,30,31. Considering that the concentration in serum proteins in general is much higher than of those produced by mammalian cells in vivo, and that lower protein concentrations result in low levels of contaminants, we suggest lsDMEM/F12 and the most favorable condition—commercial Opti-MEM as fine conditions to culture Sw71 blastocyst-like models. The attachment is an important step during peri-implantation since failure to interact would lead to infertility4,8,32. The uterine and trophoblast epithelium make their first contact via their apical cell poles for a short time within the window of implantation33. Attachment models presenting co-culture of cancer derived human endometrial epithelial cell lines (receptive: RL95-2 > HEC-1A > KLE; non-receptive AN3-CA etc.) and choriocarcinoma cell line-derived spheroids (BeWo, JAR and other) have been introduced before34,35. Our HEC-1A-Sw71 attachment model profits from the luminal epithelium adenocarcinoma origin of the HEC-1A, defining them as epithelial, polarized cells with apical pole, expressing estrogen, progesterone, and androgen receptors and from the Sw71 spheroids’ imprint, closer to the developing embryo’s trophoblast22,33,36. In addition, this cell line presented average receptivity34,35. New finding in our study was the mechanical vibrations of 1000 or 3000 rpm applied during the attachment assay. These shaking forces mimic the in vivo environment, where the blastocyst is in a continuous movement due to the beating of the epithelial cilia in the fallopian tube and within the uterus close to the site of implantation. The beating of the cilia of the oviductal epithelial cells is found to be around 5–20 Hz37, which is close to 1000 rpm (~ 17 Hz) shaking force. Moreover, the three-dimensional vibration of 56 Hz for 5 s every 60 min has been shown to increase the implantation rate in IVF37,38,39, a fact that we noted with our models when we applied 3000 (50 Hz) shaking force. Joint culture of 4 spheroids was chosen since in IVF this approach is known to improve the implantation rate. We, like others34, observed morphological changes in trophoblast spheroids’ peripheral zone as signs of epithelial-like reaction at 4th hour of co-incubation. Based on the high attachment properties (> 90%) of our Sw71 spheroids to a HEC-1A monolayer, we suggest them as an efficient model for adhesion-competent trophoblast. Further analyzes as scanning electron microscopy should be performed to give more details for this interaction. Both trophoblasts and tumor cells possess invasive behavior, but trophoblast invasion is tightly regulated and ceases once reaching the spiral arteries within the uterine myometrium40. Pregnancy disease states like recurrent miscarriage, preeclampsia and intrauterine growth retardation are often related to suboptimal trophoblast invasion within the placental bed26,41,42. On the other hand, extensive invasion may result in life-threatening conditions where trophoblast cells may rupture the uterus43. The ECM, which fills the space between cells and form the basal membranes through a complex organization of proteins and polysaccharides, imposes a biomechanical resistance that moving cells need to overcome. To invade cells might either degrade the ECM to pass through or modify their shape and squeeze through the ECM pores due to weak adhesion to the ECM and reduced or absent proteolytic activity44. These two distinct invasion modes are commonly termed “path-generating” radial (mesenchymal) and “path-finding” amoeboid mode45. Both invasion patterns are common for tumor cells to spread and a switch between them is a mechanism for an effective cancer cell invasion44,45,46,47,48,49. The vast majority of Sw71 showed the classical “path-generating” invasion pattern with well-developed invadosomes. Seems that the invasion/migration of Sw71 models is their intrinsic property although there is data showing that the contact with endometrial stromal cells promotes the trophoblast invasive activity22. Invading Sw71 spheroids present a useful platform for generation and investigation of invadosomes and their role in implantation. The invadosomes are dynamic protrusions of the plasma membrane found in both normal (podosomes) and in cancer cells (invadopodia)50,51,52. Such formations are complex molecular structures composed of a dense filamentous (F)-actin, actin-regulating proteins, and proteins involved in regulation, adhesion, and scaffolding through their metalloprotease activity53. Interestingly, live cell imaging combined with fluorescence microscopy showed that the presence of podosomes correspond with the uptake of antigens and a study revealed podosome formation in response to TGF-β or PMA, two molecules known to stimulate cell migration54. When compared to an extended cultured human embryo our 3D Sw71 model for trophoblast migration have shown many similarities like the smeared periphery due to migrating trophoblasts, the establishment of a “primitive syncytium” zone right around the spheroid where single cells could not be easily distinguished, and of a peripheral zone with single differentiated migrating trophoblast cells resembling EVTs55. Interestingly, the trophoblast cells migrate well in reduced or even no serum media, showing that the serum level is not the only determinant of migration. Moreover, Sw71 cells are programmed to migrate as they originated from 1st trimester trophoblast (placental) cells and migration is crucial for effective placentation41,56. Since serum is rich in many factors for the cell growth and development hsDMEM/F12 represents good positive control to study trophoblast migration. However, here we show that Opti-MEM™ could be chosen as a basic condition for further analyses. Unfortunately, the actual serum content in this commercial formulation is unknown57 which hinder any conclusions on this factor. Because of the known serum level and composition, the lsDMEM/F12 media may be used for collection of CM for further protein analyses since it would not interfere with the results as much as hsDMEM/F12. The serum-free media is a rather stress inducing condition, far from the physiological state, that may be used for investigation of stress factors secreted from the trophoblasts. The invading trophoblasts (EVT) is known to express a particular combination of three HLA class I molecules—HLA-G, HLA-C and HLA-E6,7,8. The non-classical HLA-G molecule is a unique marker of the trophoblasts and a central component of fetus-induced immune tolerance during pregnancy though interaction with decidual NK cells6,58. There are also suggestions for HLA-G providing a tolerogenic signal to the regulatory T cells via presentation to the uterine dendritic cells59. The trophoblast HLA-C and HLA-E molecules were shown as dominant ligands for NK cells7,8. While the HLA-E is rather monomorphic and would be considered as ‘self’ by maternal immune cells7, the polymorphic HLA-C is the only classical HLA class I molecule expressed by the trophoblasts able to present paternal antigens, as well as pathogens at maternal–fetal interface8,9,60,61. Via binding to KIRs on the maternal cytotoxic cells this molecule could influence the pregnancy outcome generating the tolerance or immunity 8,9,58,59. Thus, the expression of HLA-C by Sw71 spheroid models was of particular interest if we would like to explore them as a model in the immune HLA-C-KIR interactions. The novel finding in this study is the expression/secretion of HLA-C isoforms by the Sw71 spheroids. The similar production of sHLA-C by both Sw71 spheroids and early placenta-derived explants validate the in vivo relevance of the models.
Altogether we demonstrate that Sw71 spheroids as 3D in vitro model is a biologically relevant, useful tool for platforms for evaluation of trophectoderm behavior and functionality during the in vivo concealed process of human implantation. The 3D Sw71 models are easy to handle, select and transfer for functional assays in small volumes, where treated with different factors they can be monitored and analyzed by microscopy and with life cell imaging systems. Of note, any of the other components in the functionality assays may be replaced by primary culture or culture product for further validation. Sw71 spheroids may serve as an effective embryo surrogate for the evaluation of maternal–trophoblast immune interactions through the HLA-C-KIRs axis in (un)successful human implantation. At last, but not least the 3D models are cost effective and relatively easy to be implemented in standard equipped cell culture laboratories.
Materials and methods
Cell lines and media
Human first trimester trophoblast cells (Swan 71, Sw.71) and human endometrial epithelial cells (HEC‐1A, ATCC®HTB‐112™) were used in this study. Sw71 non-tumor cell line for the generation of the 3D models was isolated from the first trimester (7th gestational week (gw)) normal human placenta. Its variant transfected with green fluorescence protein (Sw71-GFP)20,21 was used in some of the experiments. For propagation of Sw71 cells and Sw71 spheroid differentiation DMEM‐F12 complete medium i.e., supplemented with 10% heat‐inactivated fetal calf serum (FCS), 10 mmol/L HEPES, 0.1 mmol/L MEM non‐essential amino acids, 1 mmol/L sodium pyruvate, and 100 U/mL penicillin/streptomycin (all from Gibco) was used. HEC‐1A cell line was used to mimic the endometrial epithelium and was grown in McCoy's 5A medium (ATCC), supplemented with 10% FCS, 10 mmol/L HEPES, 0.1 mmol/L MEM non‐essential amino acids, 1 mmol/L sodium pyruvate and 100 U/mL penicillin/streptomycin. To investigate the impact of the serum levels on Sw71 spheroids functionality, media with different levels of serum were tested, as follows: DMEM/F12 complete with 10% FCS, referred as high-level serum medium (hsDMEM/F12), DMEM/F12 complete with 1% FCS, referred as low-level serum medium (lsDMEM/F12), DMEM/F12 complete without serum, referred as serum-free medium (sfDMEM/F12), and commercially available Opti-MEM™/GlutaMAX™ (Opti-MEM) medium which is with reduced serum content, below 10% (Gibco). All cells were maintained at 37 °C with 95% humidity and 5% CO2.
Differentiation of Sw71 spheroids
For generation of Sw71 spheroids we used scaffold- and agitation-free technique where gravity forced aggregation of Sw71 or Sw71-GFP cells (4 × 103 cells/well) occurs in ultra-low attachment plate (ULA, Costar) after centrifugation (5 min/1500 rpm) and subsequent incubation in DMEM‐F12 complete medium for 48 h. The dynamic process of spheroid differentiation was monitored by time-lapse live cells imaging system OMNI (in brightfield mode) or by Lux3 FL (in both brightfield and fluorescence mode), both systems provided by CytoSmartTM technology (The Netherlands). The detailed brightfield, phase contrast and fluorescent images of the spheroids were taken with ECHO Revolve microscope (RVL-100-M, Echo, San Diego, CA, USA).
Attachment assay
To mimic the blastocyst-endometrial epithelium contact during attachment we co-cultured differentiated Sw71 spheroids with a confluent monolayer of HEC-1A cells for 24 h. The workflow included: (1) growing of the HEC‐1A cells in monolayer (≥ 95% confluency, 10 000 cells/well for 7 days) in McCoy's 5A complete in 96 well flat-bottomed plate (Costar) and (2) differentiation of Sw71 spheroids in DMEM-F12 complete in ULA plate (Costar) and (3) co-culture for 24 h. The day before spheroid transfer medium was switched to half McCoy’s 5A complete—half medium of interest (hsDMEM/F12, lsDMEM/F12 or Opti-MEM), each condition in triplicate). On the next day differentiated Sw71 spheroids were placed on the top of each HEC-1A monolayered well (4 per well) with wide-bore tips. After imaging the spheroids were left to adhere for 30 min, 1, 2, 4 and 24 h. At each time point the attachment rate (attached vs. placed spheroids) was determined after 3 min (min) shake at 1000 rpm or at 3000 rpm. The force of the shake of 1000 rpm corresponds to ~ 17 Hz frequency, while 3000 rpm—to 50 Hz frequency. Images were taken at each time point with ECHO Revolve microscope (RVL-100-M, Echo, San Diego, CA, USA).
Invasion and migration assays
Invasion and migration assays were performed using established protocols22. Briefly, to measure the three-dimensional invasion of differentiated Sw71 spheroids we transferred them to a flat bottom plate wells covered with solidified 50 μL Matrigel (Sigma Aldrich) in 1:1 ratio with the medium of interest (hsDMEM/F12, lsDMEM/F12 or Opti-MEM), recreating the structure of ECM, covered with 150 μL medium of interest (single spheroid per well, in triplicate for each condition). The invasion was monitored for 6 days, and images were taken every 48 h by ECHO Revolve Microscope (RVL-100-M, Echo, San Diego, CA, USA). The invasion rate (invading vs. tested spheroids) was calculated on D6, and invasion starting at D2 was considered as an optimal. For the migration assay single differentiated Sw71 spheroids were transferred into individual wells of a 96‐well plate containing the medium of interest (hsDMEM/F12, lsDMEM/F12, sfDMEM/F12 or Opti-MEM, 200 μL/well, in triplicates for each condition). The process was monitored for 48 h by live cell imaging systems OMNI or Lux3 FL (CytoSmart™ technology, The Netherlands), and was imaged every 24 h with ECHO Revolve microscope (RVL-100-M, Echo, San Diego, CA, USA). The migration rate (migrating vs. tested spheroids) and the migration area were determined on D2. The migration area equals the area without the remaining spheroid surface and the formed lacunae lacking trophoblasts and was measured using ECHO Revolve software.
Blood samples, placenta samples and trophoblasts explants
Blood samples (n = 12) and early placenta tissue samples (n = 7) were donated by healthy pregnant women in early pregnancy (6–12 gw) directed to elective abortions. Control blood samples (n = 4) were donated by non-pregnant women in reproductive age (volunteers). Gestation tissue specimens were collected in sterile phosphate-buffered saline (PBS) and processed within 1–2 h. Blood samples in serum collection tubes (KABELaboratortechnik) were incubated for 30 min/37 °C for a clot to form and then were centrifuged at 3000 rpm for 10 min, and sera were collected and stored at − 80 °C. We optimized protocol for culture of primary trophoblast derived explants from 1st trimester placenta62. Small trophoblast pieces (4–5 mm in diameter) were placed in a 24-well plate or in chamber polystyrene vessel tissue culture treated slide (Falcon) in hsDMEM/F12 complete and cultured for 72 h with daily monitoring for vitality. Conditioned media was collected at 72nd hour, centrifuged to remove any cellular material and stored at − 80 °C until use. All human samples used in this study were obtained in accordance with the guidelines of The Declaration of Helsinki and approved by Human Research Ethics Committee at the University Obstetrics and Gynecology Hospital “Maichin Dom'', Medical University, Sofia, Bulgaria (No. 250569/2018). Written informed consent was taken from all subjects for the use of tissue samples.
Immunocytochemistry
3D Sw71 models or 2D Sw71 monolayers were cultured for 24–48 h in sterile culture chambers on a glass slide (Falcon). Trophoblast derived explants were cultured in the same type of chambers for expansion of EVTs, and after that the explants were removed carefully. The cells were fixed in 2% paraformaldehyde (PFA) in PBS, overnight (ON) at RT and stained for HLA-C using indirect immunofluorescent method. After washing with PBS, the cells were incubated with 10% goat serum (to block the non-specific binding) and then subsequently with purified polyclonal rabbit anti-human HLA-C antibody (E-AB-17922, Elabscience) and AF488-conjugated goat anti-rabbit antibody (E-AB-1055, Elabscience). Negative controls were prepared by omitting primary antibody and/or secondary antibody. Control staining was done with mouse polyclonal anti-human HLA-G antibody (E-AB-18031, Elabscience) and goat anti-mouse IgG (E-AB-1015, Elabscience). The slides were imaged with ECHO Revolve microscope (RVL-100-M, Echo, San Diego, CA, USA).
Histology and immunohistochemistry (IHC)
Early pregnancy trophoblast tissues (10 mm × 10 mm × 10 mm) were fixed in formalin‐free HOPE fixative (Innovative Diagnostik‐System, Hamburg, Germany). The samples were processed and embedded in paraffin wax acc. to the manufacture’s recommendations. The paraffin sections (5 μm) were routinely stained with hematoxylin/eosin for histological investigation and then selected slides were subjected to IHC for HLA-C staining using three‐step biotin–streptavidin enzyme method. We used purified rabbit anti‐human HLA-C mAb (E-AB-17922, Elabscience) and UltraTek Anti‐Polyvalent visualization system following the recommendations of the manufacturer (SkyTec Laboratories, Logan, UT, USA). For negative control, the primary antibody was omitted. Sections from human breast cancer tissue processed in the same way were used as positive controls for specificity of HLA-C staining.
HLA-C ELISA
Conditioned media (CM) was collected from 2 and 3D Sw71 cultures, and lsDMEM/F12 condition was chosen to minimize the serum impact on further HLA-C analyses. 2D Sw71 cultures from different passages, grown ON in hsDMEM/F12 (0.175 * 106 cells per 35 mm petri dish (Corning) were cultured for another 48 h in lsDMEM/F12. Differentiated 3D Sw71 spheroids were transferred to lsDMEM/F12 for another 48 h. As a tissue primary culture that must remain vital for 72 h, the trophoblast explants were cultured in hsDMEM/F12. CM was collected at the corresponding time, centrifuged (3 min/1500 rpm) to remove any cellular debris and stored at − 80 °C until use. The samples were thawed at once and subjected to ELISA for detection of soluble HLA-C using commercial quantitative HLA-C ELISA kit (E-EL-H2331, Elabscience). CM samples were run in duplicate alongside serial dilutions of human HLA-C standard as per the manufacturer’s instructions. Serum samples (diluted 1:200) from pregnant and non-pregnant women served as a positive control for HLA-C detection. The absorption was measured at 450 nm (ELISA Microplate reader LKB 5060-006). Concentration of HLA-C was calculated from the formula gained from the automatic curve fitting using software at https://mycurvefit.com/.
Statistical analyses
Statistics was processed with GraphPad Prism v.5.0 software using Mann Whitney test (differentiation and ELISA) and One-way ANOVA (migration). Data represent the average of at least three biological replicates and are presented as mean ± SD. Statistical significance is defined as p < 0.05 (*); p < 0.005 (**); p < 0.001 (***).
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Boving, B. G. Implantation. Ann. N. Y. Acad. Sci. 75, 700–725. https://doi.org/10.1111/j.1749-6632.1959.tb44585 (1959).
Chard, T. Frequency of implantation and early pregnancy loss in natural cycles. Baillieres Clin. Obstet. Gynaecol. 5(1), 179–189. https://doi.org/10.1016/S0950-3552(05)80077-X (1991).
Clark, D. A. Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?. J. Assist. Reprod. Genet. 20(2), 63–72. https://doi.org/10.1023/A:1021788024214 (2003).
Dekel, N., Gnainsky, Y., Granot, I. & Mor, G. Inflammation and implantation. Am. J. Reprod. Immunol. 63(1), 17–21. https://doi.org/10.1111/j.1600-0897.2009.00792.x (2010).
Loke, Y. & King, A. Immunology of human placental implantation: Clinical implications of our current understanding. Mol. Med. Today https://doi.org/10.1016/S1357-4310(97)01011-3 (1997).
Ellis, S. A., Sargent, I. L., Redman, C. W. & McMichael, A. J. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 59(4), 595-601. 4 (1986).
Kovats, S. et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248(4952), 220–223 (1990).
Lee, N. et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. U. S. A. 95(9), 5199–5204. https://doi.org/10.1073/pnas.95.9.5199 (1998).
King, A. et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 21(4), 376–387. https://doi.org/10.1053/plac.1999.0496 (2000).
Steptoe, P. C. & Edwards, R. G. Birth after the reimplantation of a human embryo. Arch. Pathol. Lab. Med. 116(4), 321 (1978).
Moffett, A. & Loke, Y. W. The immunological paradox of pregnancy: A reappraisal. Placenta 25(1), 1–8. https://doi.org/10.1016/S0143-4004(03)00167-X (2004).
Matthews, K. R. W. & Moralí, D. National human embryo and embryoid research policies: A survey of 22 top research-intensive countries. Regen. Med. 15(7), 1905–1917. https://doi.org/10.2217/rme-2019-0138 (2020).
Bulgarian Ministry of Health. The Health Act. Vol. 11, 189 (2005).
Subbaraman, N. Lab-grown structures mimic human embryo’s earliest stage yet. Nature 591, 510–511 (2021).
Edmondson, R., Broglie, J. J., Adcock, A. F. & Yang, L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol. 12(4), 207–218. https://doi.org/10.1089/adt.2014.573 (2014).
Comley, J. SPHEROIDS: Rapidly becoming a preferred 3D culture format. Drug Discov. (2017). (Published online). DDW Spring 2017 issue, p 31–49.
Yu, L. et al. Blastocyst-Like Structures Generated from Human Pluripotent Stem Cells Vol. 591 (Springer US, 2021). https://doi.org/10.1038/s41586-021-03356-y.
Liu, X. et al. Modelling human blastocysts by reprogramming fibroblasts into iBlastoids. Nature 591(7851), 627–632. https://doi.org/10.1038/s41586-021-03372-y (2021).
Sozen, B. et al. Reconstructing aspects of human embryogenesis with pluripotent stem cells. Nat. Commun. 12(1), 1–13. https://doi.org/10.1038/s41467-021-25853-4 (2021).
Straszewski-Chavez, S. L. et al. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta 30(11), 939–948. https://doi.org/10.1016/j.placenta.2009.08.007 (2009).
Holmberg, J. C. et al. An in vitro model for the study of human implantation. Am. J. Reprod. Immunol. 67(2), 169–178. https://doi.org/10.1111/j.1600-0897.2011.01095.x (2012).
You, Y. et al. Novel 3D in vitro models to evaluate trophoblast migration and invasion. Am. J. Reprod. Immunol. 81(3), e13076. https://doi.org/10.1111/aji.13076 (2019).
Mor, G., Cardenas, I., Abrahams, V. & Guller, S. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann. N. Y. Acad. Sci. 1221(1), 80–87. https://doi.org/10.1111/j.1749-6632.2010.05938.x (2011).
Rachmilewitz, J. et al. The interaction between cytotrophoblasts and their derived tumor cells. Gynecol. Oncol. 57(3), 356–365 (1995).
Goshen, R. et al. Morphologic characteristics of the interaction between normal cytotrophoblasts and their malignant counterpart in the development of trophoblastic neoplasia. J. Soc. Gynecol. Investig. 3(4), 209–215 (1996).
Bilban, M. et al. Trophoblast invasion: Assessment of cellular models using gene expression signatures. Placenta 31(11), 989–996. https://doi.org/10.1016/j.placenta.2010.08.011 (2010).
Richter, K. S., Harris, D. C., Daneshmand, S. T. & Shapiro, B. S. Quantitative grading of a human blastocyst: Optimal inner cell mass size and shape. Fertil. Steril. 76(6), 1157–1167 (2001).
Ivec, M., Kovacic, B. & Vlaisavljevic, V. Prediction of human blastocyst development from morulas with delayed and/or incomplete compaction. Fertil. Steril. 96(6), 1473–1478. https://doi.org/10.1016/j.fertnstert.2011.09.015 (2011).
Menezo, Y., Testart, J. & Perrone, D. Serum is not necessary in human in vitro fertilization, early embryo culture, and transfer. Fertil. Steril. 42(5), 750–755. https://doi.org/10.1016/s0015-0282(16)48202-6 (1984).
Gruber, I. & Klein, M. Embryo culture media for human IVF: Which possibilities exist?. J. Turk. Ger. Gynecol. Assoc. 12(2), 110–117. https://doi.org/10.5152/jtgga.2011.25 (2011).
Broedel, S. E. & Papciak, S. M. The case for serum-free media. BiopProcess Int. 1, 56–58 (2003). https://www.westburg.eu/blog/serum-free-cell-culture-media.
Hartshorne, G. M. & Edwards, R. G. Role of embryonic factors in implantation: Recent developments. Baillieres Clin. Obstet. Gynaecol. 5(1), 133–158. https://doi.org/10.1016/S0950-3552(05)80075-6 (1991).
Thie, M. & Denker, H. W. In vitro studies on endometrial adhesiveness for trophoblast: Cellular dynamics in uterine epithelial cells. Cells Tissues Organs 172(3), 237–252. https://doi.org/10.1159/000066963 (2002).
John, N. J., Linke, M. & Denker, H. W. Quantitation of human choriocarcinoma spheroid attachment to uterine epithelial cell monolayers. Vitr. Cell Dev. Biol. Anim. 29(6), 461–468. https://doi.org/10.1007/BF02639380 (1993).
Ho, H., Singh, H., Aljofan, M. & Nie, G. A high-throughput in vitro model of human embryo attachment. Fertil. Steril. 97(4), 974–978. https://doi.org/10.1016/j.fertnstert.2012.01.116 (2012).
Castro-Rivera, E., Wormke, M. & Safe, S. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells. Mol. Cell Endocrinol. 150(1–2), 11–21. https://doi.org/10.1016/S0303-7207(99)00041-6 (1999).
Isachenko, V. et al. In vitro culture of human embryos with mechanical micro-vibration increases implantation rates. Reprod. Biomed. Online 22(6), 536–544. https://doi.org/10.1016/j.rbmo.2011.02.006 (2011).
El-Danasouri, I. et al. Micro-vibration culture of human embryos improves pregnancy and implantation rates. Fertil. Steril. 102(3), e217. https://doi.org/10.1016/j.fertnstert.2014.07.732 (2014).
Hur, Y. S. et al. Effect of micro-vibration culture system on embryo development. J. Assist. Reprod. Genet. 30(6), 835–841. https://doi.org/10.1007/s10815-013-0007-0 (2013).
Cohen, M. & Bischof, P. Factors regulating trophoblast invasion. Gynecol. Obstet. Investig. 64(3), 126–130. https://doi.org/10.1159/000101734 (2007).
Staun-Ram, E. & Shalev, E. Human trophoblast function during the implantation process. Reprod. Biol. Endocrinol. 3(Figure 2), 1–12. https://doi.org/10.1186/1477-7827-3-56 (2005).
Pollheimer, J. & Knöfler, M. The role of the invasive, placental trophoblast in human pregnancy. Wien. Med. Wochenschr. 162(9–10), 187–190. https://doi.org/10.1007/s10354-012-0071-6 (2012).
Jain, N., Patwardhan, S., Jain, H. & Patil, B. Surgical strategies for placenta percreta invading the bladder and review of literature. Afr. J. Urol. 26(1), 57. https://doi.org/10.1186/s12301-020-00065-2 (2020).
Brábek, J., Mierke, C. T., Rösel, D., Veselý, P. & Fabry, B. The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun. Signal. 8, 1–8. https://doi.org/10.1186/1478-811X-8-22 (2010).
Paňková, K., Rösel, D., Novotný, M. & Brábek, J. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell Mol. Life Sci. 67(1), 63–71. https://doi.org/10.1007/s00018-009-0132-1 (2010).
Wu, J. S. et al. Plasticity of cancer cell invasion: Patterns and mechanisms. Transl. Oncol. 14(1), 100899. https://doi.org/10.1016/j.tranon.2020.100899 (2021).
Hecht, I. et al. Tumor invasion optimization by mesenchymal-amoeboid heterogeneity. Sci. Rep. 5, 1–12. https://doi.org/10.1038/srep10622 (2015).
Gellersen, B., Wolf, A., Kruse, M., Schwenke, M. & Bamberger, A. M. Human endometrial stromal cell–trophoblast interactions: Mutual stimulation of chemotactic migration and promigratory roles of cell surface molecules CD82 and CEACAM. Biol. Reprod. 88(3), 1–13. https://doi.org/10.1095/biolreprod.112.106724 (2013).
Aplin, J. D. & Ruane, P. T. Embryo–epithelium interactions during implantation at a glance. J. Cell Sci. 130(1), 15–22. https://doi.org/10.1242/jcs.175943 (2017).
Hoshino, D., Branch, K. M. & Weaver, A. M. Signaling inputs to invadopodia and podosomes. J. Cell Sci. 126(14), 2979–2989. https://doi.org/10.1242/jcs.079475 (2013).
Linder, S. & Wiesner, C. Tools of the trade: Podosomes as multipurpose organelles of monocytic cells. Cell Mol. Life Sci. 72(1), 121–135. https://doi.org/10.1007/s00018-014-1731-z (2015).
Veillat, V. et al. Podosomes: Multipurpose organelles?. Int. J. Biochem. Cell Biol. 65(1), 52–60. https://doi.org/10.1016/j.biocel.2015.05.020 (2015).
Paterson, E. & Courtneidge, S. Invadosomes are coming: New insights into function and disease relevance. FEBS 285(1), 100–106. https://doi.org/10.1111/febs.14123 (2018).
Murphy, D. A. et al. A Src-Tks5 pathway is required for neural crest cell migration during embryonic development. PLoS ONE 6(7), e22499. https://doi.org/10.1371/journal.pone.0022499 (2011).
West, R. C. et al. Dynamics of trophoblast differentiation in peri-implantation–stage human embryos. Proc. Natl. Acad. Sci. U. S. A. 116(45), 22635–22644. https://doi.org/10.1073/pnas.1911362116 (2019).
Burrows, T. D., King, A. & Loke, Y. W. Trophoblast migration during human placental implantation. Hum. Reprod. Update 2(4), 307–321. https://doi.org/10.1093/humupd/2.4.307 (1996).
GIBCO Invitrogen Corporation. OPTI-MEM® I reduced serum medium. New York 2017, 2017 (2001).
Tilburgs, T., Evans, J. H., Crespo, Â. C. & Strominger, J. L. The HLA-G cycle provides for both NK tolerance and immunity at the maternal–fetal interface. Proc. Natl. Acad. Sci. U. S. A. 112(43), 13312–13317. https://doi.org/10.1073/pnas.1517724112 (2015).
Krop, J., Heidt, S., Claas, F. H. J. & Eikmans, M. Regulatory T cells in pregnancy: It is not all about FoxP3. Front. Immunol. 11(June), 1–16. https://doi.org/10.3389/fimmu.2020.01182 (2020).
Hiby, S. E. et al. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 23(4), 972–976. https://doi.org/10.1093/humrep/den011 (2008).
Papúchová, H., Meissner, T. B., Li, Q., Strominger, J. L. & Tilburgs, T. The dual role of HLA-C in tolerance and immunity at the maternal–fetal interface. Front. Immunol. 10, 2730. https://doi.org/10.3389/fimmu.2019.02730 (2019).
Genbacev, O., Schubach, S. A. & Miller, R. K. Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation. Placenta 13(5), 439–461. https://doi.org/10.1016/0143-4004(92)90051-T (1992).
Acknowledgements
This study was funded by Bulgarian National Science Fund within National Science Program VIHREN, contract number KP-06-DV-3.
Author information
Authors and Affiliations
Contributions
T.D. and M.A—conceptualization and writing of the original draft. T.D. and G.M.—reviewing and editing. M.A, D.M. and T.D.—design and implementation of the experiments. Y.Y.—optimization of the protocols for generation of Sw71 and for the functional assays, G.M.—critical reading of the manuscript. V.D.—collection of specimens and informed consent. All authors have approved the submitted manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Alexandrova, M., Manchorova, D., You, Y. et al. Functional HLA-C expressing trophoblast spheroids as a model to study placental–maternal immune interactions during human implantation. Sci Rep 12, 10224 (2022). https://doi.org/10.1038/s41598-022-12870-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-12870-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.